Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery
Considering the limitations of this retrospective study with a small sample size, anti-fibrotic perioperative treatment was associated with reduced incidence of acute exacerbation. Based on these real-world data, this pathway could be proposed as a prophylactic treatment in patients with concomitant idiopathic pulmonary fibrosis and cancer undergoing lung resection.
Authors
- Elisabetta Rosi (ORCID: https://orcid.org/0000-0002-4227-7847)
- Alberto Salvicchi (ORCID: https://orcid.org/0000-0002-9530-9830)
- Luca Voltolini (ORCID: https://orcid.org/0000-0002-2818-859X)
- Alessandro Gonfiotti (ORCID: https://orcid.org/0000-0003-2724-9474)
- Paolo Spagnolo (ORCID: https://orcid.org/0000-0002-1096-0596)
- Federico Rea (ORCID: https://orcid.org/0000-0001-7988-5101)
- Elena Bargagli (ORCID: https://orcid.org/0000-0002-8351-3703)
- Giovanni Mugnaini (ORCID: https://orcid.org/0000-0002-8358-9038)
- Stefano Bongiolatti (ORCID: https://orcid.org/0000-0003-2722-9270)
- Federico Lavorini (ORCID: https://orcid.org/0000-0002-3293-2123)
- Andrea Dell’Amore (ORCID: https://orcid.org/0000-0002-1384-7441)
Institutions
- University of Siena (IT)
- University of Padua (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Azienda Ospedaliera Universitaria Senese (IT)
- University of Florence (IT)
Publication Details
- Journal
- Life
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3390/life14111506
- Citations
- 2
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84